Hyperreflective Intraretinal Spots in Diabetics Without and with Nonproliferative Diabetic Retinopathy: an in Vivo Study Using Spectral Domain OCT

Overview

Journal J Diabetes Res

Publisher Wiley

Specialty Endocrinology

Date 2014 Jan 4

PMID 24386645

Citations 83

Authors

Stela Vujosevic

Silvia Bini

Giulia Midena

Marianna Berton

Elisabetta Pilotto

Edoardo Midena

Affiliations

Soon will be listed here.

Abstract

Purpose: To evaluate the presence of hyperreflective spots (HRS) in diabetic patients without clinically detectable retinopathy (no DR) or with nonproliferative mild to moderate retinopathy (DR) without macular edema, and compare the results to controls.

Methods: 36 subjects were enrolled: 12 with no DR, 12 with DR, and 12 normal subjects who served as controls. All studied subjects underwent full ophthalmologic examination and spectral domain optical coherence tomography (SD-OCT). SD-OCT images were analyzed to measure and localize HRS. Each image was analyzed by two independent, masked examiners.

Results: The number of HRS was significantly higher in both diabetics without and with retinopathy versus controls (P < 0.05) and in diabetics with retinopathy versus diabetics without retinopathy (P < 0.05). The HRS were mainly located in the inner retina layers (inner limiting membrane, ganglion cell layer, and inner nuclear layer). The intraobserver and interobserver agreement was almost perfect (κ > 0.9).

Conclusions: SD-OCT hyperreflective spots are present in diabetic eyes even when clinical retinopathy is undetectable. Their number increases with progressing retinopathy. Initially, HRS are mainly located in the inner retina, where the resident microglia is present. With progressing retinopathy, HRS reach the outer retinal layer. HRS may represent a surrogate of microglial activation in diabetic retina.

Citing Articles

Optical Coherence Tomography Biomarkers Predict the Long-Term Restorative Effect of Early Anti-VEGF Treatment on Diabetic Macular Edema.

Okudan S, Acar Duyan S, Erdem A, Bozkurt Oflaz A, Ozturk B Life (Basel). 2025; 15(2).

PMID: 40003678 PMC: 11857452. DOI: 10.3390/life15020269.

Enhancing diabetic retinopathy diagnosis: automatic segmentation of hyperreflective foci in OCT via deep learning.

Li Y, Yu B, Si M, Yang M, Cui W, Zhou Y Int Ophthalmol. 2025; 45(1):79.

PMID: 39966317 DOI: 10.1007/s10792-025-03439-z.

Comparison of changes in number of hyperreflective dots after intravitreal ranibizumab or dexamethasone implant in patients with branch retinal vein occlusion.

Karalezli A, Kaderli S, Kaderli A, Kaya C, Sul S Taiwan J Ophthalmol. 2024; 14(3):387-393.

PMID: 39430351 PMC: 11488816. DOI: 10.4103/tjo.TJO-D-22-00177.

Comparative Analysis of Intravitreal Dexamethasone Implant (Ozurdex) and Brolucizumab Injection in the Treatment of Diabetic Macular Edema with Hyperreflective Intraretinal Dots: A Retrospective Study.

Chakraborty S, Sheth J Clin Ophthalmol. 2024; 18:2897-2905.

PMID: 39429440 PMC: 11490259. DOI: 10.2147/OPTH.S484731.

A new texture-based labeling framework for hyper-reflective foci identification in retinal optical coherence tomography images.

Monemian M, Daneshmand P, Rakhshani S, Rabbani H Sci Rep. 2024; 14(1):22933.

PMID: 39358477 PMC: 11446929. DOI: 10.1038/s41598-024-73927-2.

References

Tang J, Kern T . Inflammation in diabetic retinopathy. Prog Retin Eye Res. 2011; 30(5):343-58. PMC: 3433044. DOI: 10.1016/j.preteyeres.2011.05.002. View

Omri S, Behar-Cohen F, de Kozak Y, Sennlaub F, Verissimo L, Jonet L . Microglia/macrophages migrate through retinal epithelium barrier by a transcellular route in diabetic retinopathy: role of PKCζ in the Goto Kakizaki rat model. Am J Pathol. 2011; 179(2):942-53. PMC: 3157258. DOI: 10.1016/j.ajpath.2011.04.018. View

Abu El-Asrar A . Role of inflammation in the pathogenesis of diabetic retinopathy. Middle East Afr J Ophthalmol. 2012; 19(1):70-4. PMC: 3277027. DOI: 10.4103/0974-9233.92118. View

Devi T, Lee I, Huttemann M, Kumar A, Nantwi K, Singh L . TXNIP links innate host defense mechanisms to oxidative stress and inflammation in retinal Muller glia under chronic hyperglycemia: implications for diabetic retinopathy. Exp Diabetes Res. 2012; 2012:438238. PMC: 3313582. DOI: 10.1155/2012/438238. View

DeBuc D, Somfai G . Early detection of retinal thickness changes in diabetes using Optical Coherence Tomography. Med Sci Monit. 2010; 16(3):MT15-21. View

Coscas G, De Benedetto U, Coscas F, Li Calzi C, Vismara S, Roudot-Thoraval F . Hyperreflective dots: a new spectral-domain optical coherence tomography entity for follow-up and prognosis in exudative age-related macular degeneration. Ophthalmologica. 2012; 229(1):32-7. DOI: 10.1159/000342159. View

Verma A, Rani P, Raman R, Pal S, Laxmi G, Gupta M . Is neuronal dysfunction an early sign of diabetic retinopathy? Microperimetry and spectral domain optical coherence tomography (SD-OCT) study in individuals with diabetes, but no diabetic retinopathy. Eye (Lond). 2009; 23(9):1824-30. DOI: 10.1038/eye.2009.184. View

Bolz M, Schmidt-Erfurth U, Deak G, Mylonas G, Kriechbaum K, Scholda C . Optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema. Ophthalmology. 2009; 116(5):914-20. DOI: 10.1016/j.ophtha.2008.12.039. View

Ogino K, Murakami T, Tsujikawa A, Miyamoto K, Sakamoto A, Ota M . Characteristics of optical coherence tomographic hyperreflective foci in retinal vein occlusion. Retina. 2011; 32(1):77-85. DOI: 10.1097/IAE.0b013e318217ffc7. View

10.

van Dijk H, Kok P, Garvin M, Sonka M, DeVries J, Michels R . Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy. Invest Ophthalmol Vis Sci. 2009; 50(7):3404-9. PMC: 2937215. DOI: 10.1167/iovs.08-3143. View

11.

Zeng H, Green W, Tso M . Microglial activation in human diabetic retinopathy. Arch Ophthalmol. 2008; 126(2):227-32. DOI: 10.1001/archophthalmol.2007.65. View

12.

Rangasamy S, McGuire P, Das A . Diabetic retinopathy and inflammation: novel therapeutic targets. Middle East Afr J Ophthalmol. 2012; 19(1):52-9. PMC: 3277025. DOI: 10.4103/0974-9233.92116. View

13.

Uji A, Murakami T, Nishijima K, Akagi T, Horii T, Arakawa N . Association between hyperreflective foci in the outer retina, status of photoreceptor layer, and visual acuity in diabetic macular edema. Am J Ophthalmol. 2011; 153(4):710-7, 717.e1. DOI: 10.1016/j.ajo.2011.08.041. View

14.

Joussen A, Doehmen S, Le M, Koizumi K, Radetzky S, Krohne T . TNF-alpha mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations. Mol Vis. 2009; 15:1418-28. PMC: 2716944. View

15.

Joussen A, Poulaki V, Le M, Koizumi K, Esser C, Janicki H . A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004; 18(12):1450-2. DOI: 10.1096/fj.03-1476fje. View

16.

Zeng X, Ng Y, Ling E . Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Vis Neurosci. 2000; 17(3):463-71. DOI: 10.1017/s0952523800173122. View

17.

Framme C, Schweizer P, Imesch M, Wolf S, Wolf-Schnurrbusch U . Behavior of SD-OCT-detected hyperreflective foci in the retina of anti-VEGF-treated patients with diabetic macular edema. Invest Ophthalmol Vis Sci. 2012; 53(9):5814-8. DOI: 10.1167/iovs.12-9950. View

18.

van Dijk H, Verbraak F, Kok P, Garvin M, Sonka M, Lee K . Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes. Invest Ophthalmol Vis Sci. 2010; 51(7):3660-5. PMC: 2904016. DOI: 10.1167/iovs.09-5041. View

19.

Rungger-Brandle E, Dosso A, Leuenberger P . Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2000; 41(7):1971-80. View

20.

van Dijk H, Verbraak F, Kok P, Stehouwer M, Garvin M, Sonka M . Early neurodegeneration in the retina of type 2 diabetic patients. Invest Ophthalmol Vis Sci. 2012; 53(6):2715-9. PMC: 3366721. DOI: 10.1167/iovs.11-8997. View